Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pranav K Gandhi

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Journal of the American Pharmacists Association : Japha|July 30, 2013
Dabigatran-dronedarone interaction in a spontaneous reporting systemPranav K Gandhi, William M Gentry, Michael B Bottorff
BMC Public Health|December 2, 2015
Adolescent body weight and health-related quality of life rated by adolescents and parents: the issue of measurement biasPranav K Gandhi, Dennis A Revicki, I-Chan Huang
Journal of Managed Care Pharmacy : JMCP|February 3, 2007
AMCP Format dossier requests: manufacturer response and formulary implications for one large health planJoshua J Spooner, Pranav K Gandhi, Susan Brown Connelly
Pharmacotherapy|October 4, 2012
Thrombotic events associated with C1 esterase inhibitor products in patients with hereditary angioedema: investigation from the United States Food and Drug Administration adverse event reporting system databasePranav K Gandhi, William M Gentry, Michael B Bottorff
Seminars in Arthritis and Rheumatism|January 29, 2013
Cardiovascular thromboembolic events associated with febuxostat: investigation of cases from the FDA adverse event reporting system databasePranav K Gandhi, William M Gentry, Michael B Bottorff
Journal of the American Pharmacists Association : Japha|January 20, 2012
SF-6D utility index as measure of minimally important difference in health status changePranav K Gandhi, L Douglas Ried, Alex Bibbey, et al.
Journal of Managed Care & Specialty Pharmacy|January 24, 2015
Cost-effectiveness analysis of allopurinol versus febuxostat in chronic gout patients: a U.S. payer perspectivePranav K Gandhi, William M Gentry, Qinli Ma, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 6, 2012
Assessment of response shift using two structural equation modeling techniquesPranav K Gandhi, L Douglas Ried, I-Chan Huang, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|November 14, 2013
Influence of explanatory and confounding variables on HRQoL after controlling for measurement bias and response shift in measurementPranav K Gandhi, L Douglas Ried, Carole L Kimberlin, et al.
Plos One|October 1, 2014
Developing item banks for measuring pediatric generic health-related quality of life: an application of the International Classification of Functioning, Disability and Health for Children and Youth and item response theoryPranav K Gandhi, Lindsay A Thompson, Sanjeev Y Tuli, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Journal of the American Pharmacists Association : Japha|July 30, 2013
Dabigatran-dronedarone interaction in a spontaneous reporting systemPranav K Gandhi, William M Gentry, Michael B Bottorff
BMC Public Health|December 2, 2015
Adolescent body weight and health-related quality of life rated by adolescents and parents: the issue of measurement biasPranav K Gandhi, Dennis A Revicki, I-Chan Huang
Journal of Managed Care Pharmacy : JMCP|February 3, 2007
AMCP Format dossier requests: manufacturer response and formulary implications for one large health planJoshua J Spooner, Pranav K Gandhi, Susan Brown Connelly
Pharmacotherapy|October 4, 2012
Thrombotic events associated with C1 esterase inhibitor products in patients with hereditary angioedema: investigation from the United States Food and Drug Administration adverse event reporting system databasePranav K Gandhi, William M Gentry, Michael B Bottorff
Seminars in Arthritis and Rheumatism|January 29, 2013
Cardiovascular thromboembolic events associated with febuxostat: investigation of cases from the FDA adverse event reporting system databasePranav K Gandhi, William M Gentry, Michael B Bottorff
Journal of the American Pharmacists Association : Japha|January 20, 2012
SF-6D utility index as measure of minimally important difference in health status changePranav K Gandhi, L Douglas Ried, Alex Bibbey, et al.
Journal of Managed Care & Specialty Pharmacy|January 24, 2015
Cost-effectiveness analysis of allopurinol versus febuxostat in chronic gout patients: a U.S. payer perspectivePranav K Gandhi, William M Gentry, Qinli Ma, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 6, 2012
Assessment of response shift using two structural equation modeling techniquesPranav K Gandhi, L Douglas Ried, I-Chan Huang, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|November 14, 2013
Influence of explanatory and confounding variables on HRQoL after controlling for measurement bias and response shift in measurementPranav K Gandhi, L Douglas Ried, Carole L Kimberlin, et al.
Plos One|October 1, 2014
Developing item banks for measuring pediatric generic health-related quality of life: an application of the International Classification of Functioning, Disability and Health for Children and Youth and item response theoryPranav K Gandhi, Lindsay A Thompson, Sanjeev Y Tuli, et al.
Pageof 2